Načítá se...
Development and Optimization of an ELISA to Quantitate C3(H(2)O) as a Marker of Human Disease
Discovery of a C3(H(2)O) uptake pathway has led to renewed interest in this alternative pathway triggering form of C3 in human biospecimens. Previously, a quantifiable method to measure C3(H(2)O), not confounded by other complement activation products, was unavailable. Herein, we describe a sensitiv...
Uloženo v:
| Vydáno v: | Front Immunol |
|---|---|
| Hlavní autoři: | , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Frontiers Media S.A.
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6458276/ https://ncbi.nlm.nih.gov/pubmed/31019515 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2019.00703 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|